Patent details
EP3697381 Title: PHARMACEUTICAL FORMULATIONS COMPRISING OPIOID RECEPTOR AGONIST AS ACTIVE INGREDIENTS, METHODS OF MANUFACTURE AND THERAPEUTIC USES THEREOF
Basic Information
- Publication number:
- EP3697381
- PCT Application Number:
- EP2018078447
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP187953245
- PCT Publication Number:
- WO2019076997
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PHARMACEUTICAL FORMULATIONS COMPRISING OPIOID RECEPTOR AGONIST AS ACTIVE INGREDIENTS, METHODS OF MANUFACTURE AND THERAPEUTIC USES THEREOF
- French Title of Invention:
- FORMULATIONS PHARMACEUTIQUES COMPRENANT DES AGONISTES DE RÉCEPTEURS OPIOÏDES COMME INGRÉDIENTS ACTIFS, LEURS PROCÉDÉS DE FABRICATION ET LEURS UTILISATIONS THÉRAPEUTIQUES
- German Title of Invention:
- PHARMAZEUTISCHE FORMULIERUNGEN MIT OPIAT-REZEPTOR-AGONIST ALS WIRKSTOFFE, VERFAHREN ZUR HERSTELLUNG UND THERAPEUTISCHE VERWENDUNGEN DAVON
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 26/06/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 30/06/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 07/06/2023
- Unitary Effect Registration Date:
- 30/06/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 17/10/2018
- Grant date:
- 07/06/2023
- EP Publication Date:
- 26/08/2020
- PCT Publication Date:
- 25/04/2019
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/06/2023
- EP B1 Publication Date:
- 07/06/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 17/10/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 31/05/2023
- Name:
- Chiesi Farmaceutici S.p.A.
- Address:
- Via Palermo, 26/A, 43122 Parma, Italy (IT)
Inventor
1
- Name:
- CAIVANO, Grazia
- Address:
- Italy (IT)
2
- Name:
- SILVA BORGES, Ana Filipa
- Address:
- Italy (IT)
Priority
- Priority Number:
- 17197466
- Priority Date:
- 20/10/2017
- Priority Country:
- European Patent Office (EPO) (EP)
Classification
- IPC classification:
- A61K 31/485; A61K 47/12; A61K 9/08; A61K 47/38; A61K 31/00; A61K 9/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202323
- Publication date:
- 07/06/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202331
- Publication date:
- 02/08/2023
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202331
- Publication date:
- 02/08/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|